Results 241 to 250 of about 9,019,286 (338)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Whole-genome sequencing bulked segregant analysis uncovered FW7, a Fusarium wilt resistance gene masked by epistasis in octoploid strawberry. [PDF]

Plant Genome
Vachev MV, Bjornson M, Pincot DDA, Famula RA, Lovell JT, Harder AM, Handley LH, Grimwood J, Brukental H, Lòpez CM, Cole GS, Feldmann MJ, Knapp SJ.   +12 more
europepmc   +1 more source

Artificial Urethral Valve Using SMA Actuators. Fundamental Principle of Valve and the Verification of Opening/Closing Functions.

, 1998
Seiji CHONAN, Seiichi Orikasa, Zhong Wei Jiang, Takasige NAMIMA, Tanaka Mami, Keiichiro Uchi, Tanikawa Jun, Kentaro Hirano   +7 more
openalex   +2 more sources

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Genome-wide association study of seed mineral nutrients in peas (Pisum sativum L.). [PDF]

Plant Genome
Sari H, Coyne CJ, Grusak MA, Valkov VA, Zhang Z, McGee RJ, Ma Y, Main D, Bandillo N, Hart J, Bourland BM, Uhdre R, Warburton ML.   +12 more
europepmc   +1 more source

ENDOTOXIN (LPS) FOLLOWING INTESTINAL ISCHEMIA/REPERFUSION DECREASES SUPERIOR MESENTERY ARTERY (SMA) BLOOD FLOW (BF)

, 1998
Lajos Bogár, Michael M. Badellino, D. Dempsev, Richard H. Turnage, L. Bartula, A. Seelig, Richard Milner, Sara Myers   +7 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

A public mid-density genotyping platform for cultivated cranberry (Vaccinium macrocarpon Aiton). [PDF]

Plant Genome
Chen S, Lin M, Taniguti CH, Tang X, de la Torre F, Sideli GM, Iorizzo M, Edger PP, Neyhart J, Zalapa J, Bassil N, Heller-Uszynska K, Zhao D, Beil CT, Sheehan MJ.   +14 more
europepmc   +1 more source

SMAs for mechanical damping

Materials Today, 2009
openaire   +2 more sources

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source